Linköping, Sweden; April 12, 2016 – For an exceptional third consecutive year, AMRA has been selected as a 33-List winner. The 33-List awards “Sweden’s 33 hottest young technology companies,” chosen jointly by the editorial staff of Swedish news magazines, NyTeknik and Affärsvärlden. To receive the 33 List award for three consecutive years is rare, and AMRA is one of only two companies to experience such an honor in 2016.
Each year, winners are selected based upon the specific innovation and youth of the company, the goal being to network entrepreneurs, venture capitalists, angel investors, researchers, journalists, politicians and officials. This year’s winners are announced and celebrated at Münchenbryggeriet in the heart of Stockholm on April 12, 2016.
AMRA’s recognition comes on the heels of an already successful year. In 2015, AMRA expanded its operations into Oslo, Norway. AMRA was then awarded the Nordic Star Award at SwedenBIO’s Nordic Life Science Days, given to three rising stars for their role in precision medicine, digitalisation, and breakthrough therapy. AMRA also revealed several international collaborations, including with the UK Biobank and Pfizer for the synergetic analysis of 7000 subjects, as well as an international co-marketing agreement with GE Healthcare.
“For all Swedish start-up companies it is a goal to be selected as a 33-List winner. To be given such an award for three years is very unusual and like a dream. It puts a quality stamp on AMRA,” says CEO Tommy Johansson. “This is an award that all our fantastic employees should be proud of and it’s a great way to attract the best talents in the industry to AMRA.”
For more information, please visit www.amramedical.com
Contact
Rosemary Shull
SVP Global BD & Marketing
rosemary.shull@amramedical.com
About AMRA
AMRA is an international medical technology company and the first in the world to transform MR images into precise body composition measurements using a cloud-based, computer-aided service.
AMRA collaborates with world-leading pharmaceutical organisations, biobanks and population cohorts, research institutions, hospitals, and clinics, aiding in the advancement of metabolic research and therapeutic application. By offering access to more accurate knowledge about our bodies, AMRA can assist the world’s medical leaders in predicting and preventing disease.
Headquartered in Sweden, AMRA was founded in 2010 as a spin-off of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT) and the Department of Medicine and Health (IMH) at Linköping University, Sweden.